By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) Reports Fourth Quarter and Fiscal Year End 2014 Financial Results and Recent Corporate Accomplishments 3/11/2015 10:29:43 AM
BioTime (BTX) Announces First Patient Treated In Pivotal Clinical Trial Of Renevia™ For HIV-Associated Lipoatrophy 2/24/2015 11:08:46 AM
ESI BIO – A Division Of BioTime (BTX), Announces Alliance Agreement With Pivotal Scientific For Distribution Of Stem Cell Products 2/23/2015 11:03:34 AM
ESI BIO – A Division Of BioTime (BTX) Announces New UK Distribution Agreement With 2BScientific 1/27/2015 10:16:41 AM
BioTime (BTX) Announces Issuance Of 14 New Patents In The Fields Of Regenerative Medicine, Stem Cell Technology, And Cancer Therapy 1/26/2015 8:35:01 AM
LifeMap Sciences, A Subsidiary Of BioTime (BTX), Announces Release Of Varelect, The Next Generation Sequencing Phenotyper 1/15/2015 7:47:12 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Appoints William Annett To Its Board Of Directors 1/12/2015 10:28:57 AM
BioTime (BTX) Appoints Adi Mohanty Chief Operating Officer 12/29/2014 7:58:37 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Completes Initial Enrollment Of Clinical Study Of Urine-Based Bladder Cancer Diagnostic 12/16/2014 11:48:21 AM
BioTime (BTX) Subsidiary ES Cell International Pte Ltd. And GE Healthcare Cross-License Patents In The Field Of Cell Assays For Drug Testing 12/16/2014 11:36:29 AM